Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
27.14
-2.05 (-7.02%)
At close: Jan 16, 2026, 4:00 PM EST
27.15
+0.01 (0.04%)
After-hours: Jan 16, 2026, 7:57 PM EST
Olema Pharmaceuticals Employees
Olema Pharmaceuticals had 96 employees as of December 31, 2024. The number of employees increased by 22 or 29.73% compared to the previous year.
Employees
96
Change (1Y)
22
Growth (1Y)
29.73%
Revenue / Employee
n/a
Profits / Employee
-$1,562,052
Market Cap
2.13B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 96 | 22 | 29.73% |
| Dec 31, 2023 | 74 | -12 | -13.95% |
| Dec 31, 2022 | 86 | 12 | 16.22% |
| Dec 31, 2021 | 74 | 37 | 100.00% |
| Dec 31, 2020 | 37 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
OLMA News
- 3 days ago - Olema Pharmaceuticals, Inc. (OLMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 13 days ago - Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 13 days ago - Olema Oncology to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 25 days ago - Olema: 'Strong Buy' Maintained On OPERA-02 Trial Initiation & Additional Shots On Goal - Seeking Alpha
- 2 months ago - Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 2 months ago - Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 2 months ago - Olema Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 2 months ago - Why biotech and drug stocks are on the mend even though the rest of the market is hurting - Market Watch